NNC-711, a novel potent and selective γ-aminobutyric acid uptake inhibitor: pharmacological characterization

Peter D. Suzdak(Novo Holdings (Denmark)), Erik B. Nielsen(Novo Holdings (Denmark)), Lars J. S. Knutsen, Per O. Sørensen(Novo Nordisk (Denmark)), Knud Erik Andersen(Novo Holdings (Denmark)), Kristen Frederiksen(Mayo Clinic in Florida)

European Journal of Pharmacology

December 1, 1992

10.1016/0014-2999(92)90804-d

Cited by 160

Related Papers

Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder

|Journal of Medicinal Chemistry|2011|602

Proliferation and differentiation of rat neuroepithelial precursor cells in vivo

|Journal of Neuroscience|1988|560

Immortalization of precursor cells from the mammalian CNS

|Neuron|1988|326

<i>(R)‐N</i>‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake Carrier

|Journal of Neurochemistry|1990|228

Bioisosteres of Arecoline: 1,2,3,6-Tetrahydro-5-pyridyl-Substituted and 3-Piperidyl-Substituted Derivatives of Tetrazoles and 1,2,3-Triazoles. Synthesis and Muscarinic Activity

|Journal of Medicinal Chemistry|1994|96